QUALCOMM INC/DE, 10-Q filed on 4/22/2015
Quarterly Report
Document and Entity Information Document
6 Months Ended
Mar. 29, 2015
Apr. 20, 2015
Document Information [Line Items]
 
 
Entity Registrant Name
QUALCOMM INC/DE 
 
Entity Registrant State of Incorporation
Delaware 
 
Entity Address
5775 Morehouse Dr. 
 
Entity City
San Diego 
 
Entity State
California 
 
Entity Zip Code
92121-1714 
 
Entity Phone Number
(858) 587-1121 
 
Entity Employer ID
953685934 
 
Entity Central Index Key
0000804328 
 
Current Fiscal Year End Date
--09-27 
 
Entity Filer Category
Large Accelerated Filer 
 
Document Type
10-Q 
 
Document Period End Date
Mar. 29, 2015 
 
Document Fiscal Year Focus
2015 
 
Document Fiscal Period Focus
Q2 
 
Amendment Flag
false 
 
Entity Common Stock, Shares Outstanding
 
1,629,569,117 
Entity Well-known Seasoned Issuer
Yes 
 
Entity Voluntary Filers
No 
 
Entity Current Reporting Status
Yes 
 
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Millions, unless otherwise specified
Mar. 29, 2015
Sep. 28, 2014
Current assets:
 
 
Cash and cash equivalents
$ 5,492 
$ 7,907 
Marketable securities
10,063 
9,658 
Accounts receivable, net
2,058 
2,412 
Inventories
1,861 
1,458 
Deferred tax assets
533 
577 
Other current assets
733 
401 
Total current assets
20,740 
22,413 
Marketable securities
14,055 
14,457 
Deferred tax assets
1,049 
1,174 
Property, plant and equipment, net
2,523 
2,487 
Goodwill
4,388 
4,488 
Other intangible assets, net
2,482 
2,580 
Other assets
1,936 
975 
Total assets
47,173 
48,574 
Current liabilities:
 
 
Trade accounts payable
1,683 
2,183 
Payroll and other benefits related liabilities
744 
802 
Unearned revenues
778 
785 
Short-term debt
1,096 
Other current liabilities
1,868 
2,243 
Total current liabilities
6,169 
6,013 
Unearned revenues
2,667 
2,967 
Other liabilities
503 
428 
Total liabilities
9,339 
9,408 
Commitments and contingencies (Note 7)
   
   
Qualcomm stockholders' equity:
 
 
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,633 and 1,669 shares issued and outstanding, respectively
4,956 
7,736 
Retained earnings
32,411 
30,799 
Accumulated other comprehensive income
472 
634 
Total Qualcomm stockholders' equity
37,839 
39,169 
Noncontrolling interests
(5)
(3)
Total stockholders' equity
37,834 
39,166 
Total liabilities and stockholders' equity
$ 47,173 
$ 48,574 
CONDENSED CONSOLIDATED BALANCE SHEETS PARENTHETICALS (USD $)
In Millions, except Per Share data, unless otherwise specified
Mar. 29, 2015
Sep. 28, 2014
Preferred stock, par value
$ 0.0001 
$ 0.0001 
Preferred stock, shares authorized
Preferred stock, shares outstanding
Common stock, par value
$ 0.0001 
$ 0.0001 
Common stock, shares authorized
6,000 
6,000 
Common stock, shares issued
1,633 
1,669 
Common stock, shares outstanding
1,633 
1,669 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Revenues:
 
 
 
 
Equipment and services
$ 4,403 
$ 4,229 
$ 9,619 
$ 8,881 
Licensing
2,491 
2,138 
4,374 
4,108 
Total revenues
6,894 
6,367 
13,993 
12,989 
Costs and expenses:
 
 
 
 
Cost of equipment and services revenues
2,628 
2,482 
5,676 
5,189 
Research and development
1,375 
1,356 
2,726 
2,683 
Selling, general and administrative
545 
539 
1,112 
1,162 
Other
1,010 
1,079 
472 
Total costs and expenses
5,558 
4,377 
10,593 
9,506 
Operating income
1,336 
1,990 
3,400 
3,483 
Investment income, net (Note 3)
203 
282 
437 
546 
Income from continuing operations before income taxes
1,539 
2,272 
3,837 
4,029 
Income tax expense
(487)
(314)
(814)
(626)
Income from continuing operations
1,052 
1,958 
3,023 
3,403 
Discontinued operations, net of income taxes (Note 10)
430 
Net income
1,052 
1,958 
3,023 
3,833 
Net loss attributable to noncontrolling interests
Net income attributable to Qualcomm
$ 1,053 
$ 1,959 
$ 3,025 
$ 3,835 
Basic earnings per share attributable to Qualcomm:
 
 
 
 
Continuing operations
$ 0.64 
$ 1.16 
$ 1.83 
$ 2.02 
Discontinued operations
$ 0.00 
$ 0.00 
$ 0.00 
$ 0.25 
Net income
$ 0.64 
$ 1.16 
$ 1.83 
$ 2.27 
Diluted earnings per share attributable to Qualcomm:
 
 
 
 
Continuing operations
$ 0.63 
$ 1.14 
$ 1.80 
$ 1.98 
Discontinued operations
$ 0.00 
$ 0.00 
$ 0.00 
$ 0.25 
Net income
$ 0.63 
$ 1.14 
$ 1.80 
$ 2.23 
Shares used in per share calculations:
 
 
 
 
Basic
1,645 
1,688 
1,653 
1,688 
Diluted
1,667 
1,719 
1,677 
1,721 
Dividends per share announced
$ 0.42 
$ 0.35 
$ 0.84 
$ 0.70 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Net income
$ 1,052 
$ 1,958 
$ 3,023 
$ 3,833 
Other comprehensive income (loss), net of income taxes:
 
 
 
 
Foreign currency translation (losses) gains
(10)
(31)
Reclassification of foreign currency translation losses included in net income
Noncredit other-than-temporary impairment losses and subsequent changes in fair value related to certain available-for-sale debt securities
(1)
(10)
Reclassification of other-than-temporary losses on available-for-sale securities included in net income
19 
72 
60 
92 
Net unrealized gains (losses) on other available-for-sale marketable securities
98 
102 
(6)
179 
Reclassification of net realized gains on available-for-sale securities included in net income
(64)
(144)
(175)
(217)
Net unrealized gains on derivative instruments
Reclassification of net realized gains on derivative instruments included in net income
(7)
(13)
Total other comprehensive income (loss)
44 
25 
(162)
57 
Total comprehensive income
1,096 
1,983 
2,861 
3,890 
Comprehensive loss attributable to noncontrolling interests
Comprehensive income attributable to Qualcomm
$ 1,097 
$ 1,984 
$ 2,863 
$ 3,892 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Operating Activities:
 
 
Net income
$ 3,023 
$ 3,833 
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
Depreciation and amortization expense
591 
561 
Gain on sale of discontinued operations
(665)
Long-lived asset and goodwill impairment charges
138 
479 
Income tax provision in excess of income tax payments
73 
268 
Non-cash portion of share-based compensation expense
522 
532 
Incremental tax benefits from share-based compensation
(78)
(169)
Net realized gains on marketable securities and other investments
(277)
(388)
Impairment losses on marketable securities and other investments
106 
159 
Other items, net
(30)
(20)
Changes in assets and liabilities:
 
 
Accounts receivable, net
338 
(96)
Inventories
(403)
153 
Other assets
(1,138)
127 
Trade accounts payable
(508)
35 
Payroll, benefits and other liabilities
(405)
(102)
Unearned revenues
(246)
(112)
Net cash provided by operating activities
1,706 
4,595 
Investing Activities:
 
 
Capital expenditures
(449)
(797)
Purchases of available-for-sale securities
(8,758)
(7,827)
Proceeds from sales and maturities of available-for-sale securities
8,631 
5,684 
Purchases of trading securities
(695)
(1,814)
Proceeds from sales and maturities of trading securities
710 
1,793 
Proceeds from sale of discontinued operations, net of cash sold
788 
Acquisitions and other investments, net of cash acquired
(178)
(347)
Other items, net
49 
62 
Net cash used by investing activities
(690)
(2,458)
Financing Activities:
 
 
Proceeds from issuance of common stock
417 
953 
Repurchases and retirements of common stock
(3,611)
(2,004)
Dividends paid
(1,385)
(1,179)
Proceeds from short-term debt
1,095 
Incremental tax benefits from share-based compensation
78 
169 
Change in obligations under securities lending
(2)
123 
Other items, net
(8)
(3)
Net cash used by financing activities
(3,416)
(1,941)
Effect of exchange rate changes on cash and cash equivalents
(15)
(1)
Net (decrease) increase in cash and cash equivalents
(2,415)
195 
Cash and cash equivalents at beginning of period
7,907 
6,142 
Cash and cash equivalents at end of period
$ 5,492 
$ 6,337 
Basis of Presentation
Basis of Presentation
Note 1 — Basis of Presentation
Financial Statement Preparation. These condensed consolidated financial statements have been prepared by QUALCOMM Incorporated (collectively with its subsidiaries, the Company or Qualcomm) in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all normal recurring adjustments necessary for a fair statement of the results for the interim periods. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2014. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. The Company operates and reports using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three-month and six-month periods ended March 29, 2015 and March 30, 2014 included 13 weeks and 26 weeks, respectively.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation.
Earnings Per Common Share. Basic earnings per common share are computed by dividing net income attributable to Qualcomm by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per common share are computed by dividing net income attributable to Qualcomm by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans and shares subject to written put options, if any, and the weighted-average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money share equivalents, which are calculated based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an award, if any, the amount of compensation cost for future service that the Company has not yet recognized, if any, and the estimated tax benefits that would be recorded in paid-in capital when an award is settled, if any, are assumed to be used to repurchase shares in the current period. The dilutive common share equivalents, calculated using the treasury stock method, for the three and six months ended March 29, 2015 were 21,588,000 and 23,295,000, respectively. The dilutive common share equivalents, calculated using the treasury stock method, for the three and six months ended March 30, 2014 were 30,989,000 and 32,656,000, respectively. Shares of common stock equivalents outstanding that were not included in the computation of diluted earnings per common share because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period were 18,000 and 744,000 during the three and six months ended March 29, 2015, respectively, and 12,000 and 413,000 during the three and six months ended March 30, 2014, respectively.
Share-Based Compensation. Total share-based compensation expense, related to all of the Company’s share-based awards, was comprised as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30,
2014
 
March 29,
2015
 
March 30,
2014
Cost of equipment and services revenues
$
11

 
$
13

 
$
23

 
$
25

Research and development
158

 
163

 
333

 
336

Selling, general and administrative
80

 
75

 
166

 
171

Share-based compensation expense before income taxes
249

 
251

 
522

 
532

Related income tax benefit
(43
)
 
(53
)
 
(86
)
 
(109
)
 
$
206

 
$
198

 
$
436

 
$
423

The Company recorded $81 million and $82 million in share-based compensation expense during the six months ended March 29, 2015 and March 30, 2014, respectively, related to share-based awards granted during those periods. At March 29, 2015, total unrecognized compensation expense related to non-vested restricted stock units granted prior to that date was $1.3 billion, which is expected to be recognized over a weighted-average period of 1.8 years. During the six months ended March 29, 2015 and March 30, 2014, net share-based awards granted, after forfeitures and cancelations, represented 0.4% of outstanding shares as of the beginning of each fiscal period, and total share-based awards granted represented 0.5% of outstanding shares as of the end of each fiscal period.
Recent Accounting Pronouncements. In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers,” which outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. The new standard requires a company to recognize revenue upon transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. ASU 2014-09 defines a five-step approach for recognizing revenue, which may require a company to use more judgment and make more estimates than under the current guidance. The ASU as currently issued will be effective for the Company starting in the first quarter of fiscal 2018. On April 1, 2015, the FASB voted to propose a one-year deferral to the effective date, but to permit entities to adopt one year earlier if they choose (i.e., the original effective date). The proposal will be subject to the FASB’s due process requirement, which includes a period for public comments. The new standard allows for two methods of adoption: (a) full retrospective adoption, meaning the standard is applied to all periods presented, or (b) modified retrospective adoption, meaning the cumulative effect of applying the new standard is recognized as an adjustment to the opening retained earnings balance. The Company is in the process of determining the adoption method as well as the effects the adoption will have on its consolidated financial statements.
Composition of Certain Financial Statement Items
Composition of Certain Financial Statement Items
Note 2 — Composition of Certain Financial Statement Items

Accounts Receivable (in millions)
 
 
 
 
March 29,
2015
 
September 28,
2014
Trade, net of allowances for doubtful accounts of $5 and $5, respectively
$
2,040

 
$
2,362

Long-term contracts
11

 
17

Other
7

 
33

 
$
2,058

 
$
2,412


Inventories (in millions)
 
 
 
 
March 29,
2015
 
September 28,
2014
Raw materials
$
1

 
$
1

Work-in-process
903

 
656

Finished goods
957

 
801

 
$
1,861

 
$
1,458

 
Other Current Liabilities (in millions)
 
 
 
 
March 29,
2015
 
September 28,
2014
Customer incentives and other customer-related liabilities
$
1,452

 
$
1,777

Other
416

 
466

 
$
1,868

 
$
2,243

Investment Income, Net
Investment Income, Net (in millions)
Note 3 — Investment Income, Net (in millions)
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30,
2014
 
March 29,
2015
 
March 30,
2014
Interest and dividend income
$
138

 
$
167

 
$
272

 
$
322

Interest expense
(1
)
 
(3
)
 
(2
)
 
(5
)
Net realized gains on marketable securities
108

 
243

 
264

 
371

Net realized gains on other investments
3

 

 
13

 
17

Impairment losses on marketable securities
(27
)
 
(112
)
 
(89
)
 
(141
)
Impairment losses on other investments
(14
)
 
(11
)
 
(17
)
 
(18
)
Net gains on derivative instruments
2

 

 
6

 
4

Equity in net losses of investees
(9
)
 
(4
)
 
(13
)
 
(5
)
Net gains on deconsolidation of subsidiaries
3

 
2

 
3

 
1

 
$
203

 
$
282

 
$
437

 
$
546

Income Taxes
Income Taxes
Note 4 — Income Taxes
The Company estimates its annual effective income tax rate for continuing operations to be approximately 21% for fiscal 2015, which is greater than its 14% effective income tax rate for fiscal 2014. Tax benefits from foreign income taxed at rates lower than rates in the United States are expected to be approximately 17% in fiscal 2015, compared to 20% in fiscal 2014.
During the second quarter of fiscal 2015, the China National Development and Reform Commission (NDRC) imposed a $975 million fine on the Company (Note 7). The fine is not deductible for tax purposes. Given the significant unusual nature of the fine, it was accounted for discretely in the second quarter of fiscal 2015. Also, during the second quarter of fiscal 2015, the Company recorded a $61 million tax benefit as a result of a favorable tax audit settlement with the Internal Revenue Service related to Qualcomm Atheros, Inc.’s pre-acquisition 2010 and 2011 tax returns.
During the first quarter of fiscal 2015, the United States government reinstated the federal research and development tax credit retroactively to January 1, 2014 through December 31, 2014. As a result of the reinstatement, the Company recorded a tax benefit of $101 million related to fiscal 2014 in the first quarter of fiscal 2015. Additionally, the estimated annual effective tax rate for fiscal 2015 reflects the United States federal research and development tax credit generated through December 31, 2014, the date on which the credit expired. The annual effective tax rate for fiscal 2014 reflected the tax benefit from the credit generated through December 31, 2013, the date on which the credit previously expired.
The effective tax rate of 32% for the second quarter of fiscal 2015 was greater than the estimated annual effective tax rate of 21% primarily as a result of the NDRC fine, partially offset by the favorable tax audit settlement.
Stockholders' Equity
Stockholders' Equity
Note 5 — Stockholders’ Equity
Changes in stockholders’ equity for the six months ended March 29, 2015 were as follows (in millions):
 
Qualcomm Stockholders’ Equity
 
Noncontrolling Interests
 
Total Stockholders’ Equity
Balance at September 28, 2014
$
39,169

 
$
(3
)
 
$
39,166

Net income (loss)
3,025

 
(2
)
 
3,023

  Other comprehensive loss
(162
)
 

 
(162
)
Common stock issued under employee benefit plans and related tax benefits
476

 

 
476

Share-based compensation
548

 

 
548

Tax withholding related to vesting of restricted stock units
(193
)
 

 
(193
)
Dividends
(1,412
)
 

 
(1,412
)
Stock repurchases
(3,611
)
 

 
(3,611
)
Other
(1
)
 

 
(1
)
Balance at March 29, 2015
$
37,839

 
$
(5
)
 
$
37,834


Accumulated Other Comprehensive Income. Changes in the components of accumulated other comprehensive income, net of income taxes, in Qualcomm stockholders’ equity during the six months ended March 29, 2015 were as follows (in millions):
 
Foreign Currency Translation Adjustment
 
Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities
 
Net Unrealized Gain (Loss) on Other Available-for-Sale Securities
 
Total Accumulated Other Comprehensive Income
Balance at September 28, 2014
$
(113
)
 
$
24

 
$
723

 
$
634

Other comprehensive loss before reclassifications
(31
)
 
(7
)
 
(6
)
 
(44
)
Reclassifications from accumulated other comprehensive income

 
4

 
(122
)
 
(118
)
Other comprehensive loss
(31
)
 
(3
)
 
(128
)
 
(162
)
Balance at March 29, 2015
$
(144
)
 
$
21

 
$
595

 
$
472


Reclassifications from accumulated other comprehensive income related to available-for-sale securities and foreign currency translation adjustment of $47 million and $118 million for the three and six months ended March 29, 2015, respectively, and $71 million and $124 million for the three and six months ended March 30, 2014, respectively, were recorded in investment income, net (Note 3). Reclassifications from accumulated other comprehensive income related to derivative instruments of $7 million and $13 million for the three and six months ended March 30, 2014, respectively, were recorded in revenues, cost of equipment and services revenues, research and development expenses and selling, general and administrative expenses.
Stock Repurchase Program. On March 9, 2015, the Company announced a stock repurchase program authorizing it to repurchase up to $15 billion of the Company’s common stock. The stock repurchase program has no expiration date. The $15 billion stock repurchase program replaced a $7.8 billion stock repurchase program announced on March 4, 2014, of which $2.1 billion remained authorized for repurchase. During the six months ended March 29, 2015 and March 30, 2014, the Company repurchased and retired 50,699,000 and 27,586,000 shares of common stock, respectively, for $3.6 billion and $2.0 billion, respectively, before commissions. At March 29, 2015, approximately $14.5 billion remained authorized for repurchase under the Company’s stock repurchase program. Since March 29, 2015, the Company repurchased and retired 5,061,000 shares of common stock for $345 million.
Dividends. On March 9, 2015, the Company announced a 14% increase in its quarterly cash dividend per share of common stock from $0.42 to $0.48, which is effective for dividends payable after March 25, 2015. On April 8, 2015, the Company announced a cash dividend of $0.48 per share on the Company’s common stock, payable on June 24, 2015 to stockholders of record as of the close of business on June 3, 2015. During the six months ended March 29, 2015 and March 30, 2014, dividends charged to retained earnings were as follows (in millions, except per share data):
 
2015
 
2014
 
Per Share
 
Total
 
Per Share
 
Total
First quarter
$
0.42

 
$
710

 
$
0.35

 
$
599

Second quarter
0.42

 
702

 
0.35

 
599

 
$
0.84

 
$
1,412

 
$
0.70

 
$
1,198

Debt
Debt Disclosure [Text Block]
Note 6 — Debt
In February 2015, the Company entered into a Revolving Credit Facility that provides for unsecured revolving facility loans, swing line loans and letters of credit in an aggregate amount of up to $4.0 billion, expiring in February 2020. Proceeds from the Revolving Credit Facility will be used for general corporate purposes. Loans under the Revolving Credit Facility bear interest, at the option of the Company, at either LIBOR (determined in accordance with the Revolving Credit Facility) plus a margin of 0.7% per annum or the Base Rate (determined in accordance with the Revolving Credit Facility), plus an initial margin of 0% per annum. The Revolving Credit Facility has a facility fee, which initially accrues at a rate of 0.05% per annum. The Revolving Credit Facility requires that the Company comply with certain covenants, including one financial covenant to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in the Revolving Credit Facility, of not less than three to one at the end of each fiscal quarter. At March 29, 2015, the Company was in compliance with the financial covenant, and the Company had not borrowed any funds under the Revolving Credit Facility.
In March 2015, the Company began an unsecured commercial paper program, which provides for the issuance of up to $4.0 billion of commercial paper. Net proceeds from this program are used for general corporate purposes. Maturities of commercial paper can range from 1 day to up to 397 days. At March 29, 2015, the Company had $1.1 billion of outstanding commercial paper recorded as short-term debt with a weighted-average interest rate of 0.14%, which included fees paid to the commercial paper dealers, and weighted-average remaining days to maturity of 58 days. The carrying value of the outstanding commercial paper approximated its estimated fair value at March 29, 2015.
Commitments and Contingencies
Commitments and Contingencies
Note 7 — Commitments and Contingencies
Legal Proceedings. ParkerVision, Inc. v. QUALCOMM Incorporated: On July 20, 2011, ParkerVision filed a complaint against the Company in the United States District Court for the Middle District of Florida alleging that certain of the Company’s products infringe seven of its patents alleged to cover direct down-conversion receivers. ParkerVision’s complaint sought damages and injunctive and other relief. Subsequently, ParkerVision narrowed its allegations to assert only four patents. On October 17, 2013, the jury returned a verdict finding all asserted claims of the four at-issue patents to be infringed and finding that none of the asserted claims are invalid. On October 24, 2013, the jury returned a separate verdict assessing total past damages of approximately $173 million and finding that the Company’s infringement was not willful. The Company recorded the verdict amount in fiscal 2013 as a charge in other expenses. Post-verdict motions, including the Company’s motions for judgment as a matter of law and a new trial on invalidity and non-infringement and ParkerVision’s motions for injunctive relief and ongoing royalties, were filed by January 24, 2014. A hearing on these motions was held on May 1, 2014. On June 20, 2014, the court granted the Company’s motion to overturn the infringement verdict, denied the Company’s motion to overturn the invalidity verdict, and denied the remaining motions as moot. The court then entered judgment in the Company’s favor. As a result of the court’s judgment, the Company is not liable for any damages to ParkerVision, and therefore, the Company reversed all recorded amounts related to the damages verdict in fiscal 2014. On June 25, 2014, ParkerVision filed a notice of appeal with the court. The Court of Appeals for the Federal Circuit will hear the appeal on May 8, 2015 and issue a decision sometime thereafter. On May 1, 2014, ParkerVision filed another complaint against the Company in the United States District Court for the Middle District of Florida alleging patent infringement. On August 21, 2014, ParkerVision amended the compliant, now captioned ParkerVision, Inc. v. QUALCOMM Incorporated, Qualcomm Atheros, Inc., HTC Corporation, HTC America, Inc., Samsung Electronics Co., LTD., Samsung Electronics America, Inc. and Samsung Telecommunications America, LLC, broadening the allegations. ParkerVision now alleges that the Company infringes 11 additional patents and seeks damages and injunctive and other relief. The Company was served with the complaint in this second action on August 28, 2014 and answered on November 17, 2014. The judge’s schedule sets the claim construction hearing for August 12, 2015, the close of discovery for January 2016 and the trial for August 2016.
Nvidia Corporation v. Qualcomm Incorporated: On September 4, 2014, Nvidia filed a complaint in the United States District Court for the District of Delaware and also with the United States International Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930 against the Company, Samsung Electronics Co., Ltd., and other Samsung entities, alleging infringement of seven patents related to graphics processing. In the ITC complaint, Nvidia seeks an exclusion order barring the importation of certain consumer electronics and display device products, including some that incorporate the Company’s chip products, that infringe, induce infringement and/or contribute to the infringement of at least one of the seven asserted graphics processing patents as well as a cease and desist order preventing the Company from carrying out commercial activities within the United States related to such products. In the District of Delaware complaint, Nvidia is seeking an award of damages for the infringement of the asserted patents, a finding that such infringement is willful and treble damages for such willful infringement, and an order permanently enjoining the Company from infringing the asserted patents. The ITC instituted an investigation into Nvidia’s allegations on October 6, 2014. On April 2, 2015, the Administrative Law Judge in the ITC investigation issued a claim construction order construing seven claim terms from five of the seven asserted patents. The evidentiary hearing for the investigation is set for June 22 to June 26, 2015. The Initial Determination of the Administrative Law Judge is due October 9, 2015, and the target date for completion of the investigation by the ITC is set for February 10, 2016. The district court case was stayed on October 23, 2014 pending completion of the ITC investigation including appeals.
Icera Complaint to the European Commission (Commission): On June 7, 2010, the Commission notified and provided the Company with a redacted copy of a complaint filed with the Commission by Icera, Inc. (subsequently acquired by Nvidia Corporation) alleging that the Company has engaged in anticompetitive activity. The Company was asked by the Commission to submit a preliminary response to the portions of the complaint disclosed to it, and the Company submitted its response in July 2010. Subsequently, the Company has provided and continues to provide additional documents and information as requested by the Commission. The Company continues to cooperate with the Commission’s preliminary investigation.
Korea Fair Trade Commission (KFTC) Complaint: On January 4, 2010, the KFTC issued a written decision finding that the Company had violated South Korean law by offering certain discounts and rebates for purchases of its CDMA chips and for including in certain agreements language requiring the continued payment of royalties after all licensed patents have expired. The KFTC levied a fine, which the Company paid and recorded as an expense in fiscal 2010. The Company appealed to the Seoul High Court, and on June 19, 2013, the Seoul High Court affirmed the KFTC’s decision. On July 4, 2013, the Company filed an appeal with the Korea Supreme Court. There have been no material developments during fiscal 2015 with respect to this matter.
Japan Fair Trade Commission (JFTC) Complaint: The JFTC received unspecified complaints alleging that the Company’s business practices are, in some way, a violation of Japanese law. On September 29, 2009, the JFTC issued a cease and desist order concluding that the Company’s Japanese licensees were forced to cross-license patents to the Company on a royalty-free basis and were forced to accept a provision under which they agreed not to assert their essential patents against the Company’s other licensees who made a similar commitment in their license agreements with the Company. The cease and desist order seeks to require the Company to modify its existing license agreements with Japanese companies to eliminate these provisions while preserving the license of the Company’s patents to those companies. The Company disagrees with the conclusions that it forced its Japanese licensees to agree to any provision in the parties’ agreements and that those provisions violate the Japanese Antimonopoly Act. The Company has invoked its right under Japanese law to an administrative hearing before the JFTC. In February 2010, the Tokyo High Court granted the Company’s motion and issued a stay of the cease and desist order pending the administrative hearing before the JFTC. The JFTC has held hearings on 26 different dates, with the next hearing scheduled for May 25, 2015.
Securities and Exchange Commission (SEC) Formal Order of Private Investigation and Department of Justice Investigation: On September 8, 2010, the Company was notified by the SEC’s Los Angeles Regional office of a formal order of private investigation. The Company understands that the investigation arose from a “whistleblower’s” allegations made in December 2009 to the audit committee of the Company’s Board of Directors and to the SEC. In 2010, the audit committee completed an internal review of the allegations with the assistance of independent counsel and independent forensic accountants. This internal review into the whistleblower’s allegations and related accounting practices did not identify any errors in the Company’s financial statements. On January 27, 2012, the Company learned that the U.S. Attorney’s Office for the Southern District of California/Department of Justice (collectively, DOJ) had begun an investigation regarding the Company’s compliance with the Foreign Corrupt Practices Act (FCPA). As discussed below, FCPA compliance is also the focus of the SEC investigation. The audit committee conducted an internal review of the Company’s compliance with the FCPA and its related policies and procedures with the assistance of independent counsel and independent forensic accountants. The audit committee has completed this comprehensive review, made findings consistent with the Company’s findings described below and suggested enhancements to the Company’s overall FCPA compliance program. In part as a result of the audit committee’s review, the Company has made and continues to make enhancements to its FCPA compliance program, including implementation of the audit committee’s recommendations.
As previously disclosed, the Company discovered, and as a part of its cooperation with these investigations informed the SEC and the DOJ of, instances in which special hiring consideration, gifts or other benefits (collectively, benefits) were provided to several individuals associated with Chinese state-owned companies or agencies. Based on the facts currently known, the Company believes the aggregate monetary value of the benefits in question to be less than $250,000, excluding employment compensation.
On March 13, 2014, the Company received a Wells Notice from the SEC’s Los Angeles Regional Office indicating that the staff has made a preliminary determination to recommend that the SEC file an enforcement action against the Company for violations of the anti-bribery, books and records and internal control provisions of the FCPA. The bribery allegations relate to benefits offered or provided to individuals associated with Chinese state-owned companies or agencies. The Wells Notice indicated that the recommendation could involve a civil injunctive action and could seek remedies that include disgorgement of profits, the retention of an independent compliance monitor to review the Company’s FCPA policies and procedures, an injunction, civil monetary penalties and prejudgment interest.
A Wells Notice is not a formal allegation or finding by the SEC of wrongdoing or violation of law. Rather, the purpose of a Wells Notice is to give the recipient an opportunity to make a “Wells submission” setting forth reasons why the proposed enforcement action should not be filed and/or bringing additional facts to the SEC’s attention before any decision is made by the SEC as to whether to commence a proceeding. On April 4, 2014 and May 29, 2014, the Company made Wells submissions to the staff of the Los Angeles Regional Office explaining why the Company believes it has not violated the FCPA and therefore enforcement action is not warranted.
The Company is continuing to cooperate with the SEC and the DOJ, but is unable to predict the outcome of their investigations or any actions that the SEC or DOJ may decide to file.
China National Development and Reform Commission (NDRC) Investigation: In November 2013, the NDRC notified the Company that it had commenced an investigation of the Company relating to China’s Anti-Monopoly Law (AML). The investigation concerned primarily the Company’s licensing business and certain interactions between the Company’s licensing business and its chipset business. On February 9, 2015, the Company announced that it had reached a resolution with the NDRC regarding the investigation. The NDRC issued an Administrative Sanction Decision finding that the Company had violated the AML, and the Company agreed to implement a rectification plan that modifies certain of its business practices in China. The NDRC has reviewed that plan and stated that it satisfies their decision. The Company will not pursue further legal proceedings contesting the NDRC’s findings.
The key terms of the rectification plan provide that the Company will offer licenses for devices under its current 3G and 4G essential Chinese patents separately from licenses to its other patents and will provide patent lists during the negotiation process. If the Company seeks a cross license from a Chinese licensee as part of such offer, it will negotiate with the licensee in good faith and provide fair consideration for such rights. For licenses of the Company’s 3G and 4G essential Chinese patents for branded devices sold for use in China starting on January 1, 2015, the Company will charge running royalties of 5% for 3G CDMA or WCDMA devices (including multimode 3G/4G devices) and 3.5% for 4G devices that do not implement CDMA or WCDMA (including 3-mode LTE-TDD devices), in each case using a royalty base of 65% of the net selling price of the device. Consistent with the plan, the Company has offered its existing licensees the revised terms for sales of devices for use in China. The plan also provides that the Company will not condition the sale of baseband chipsets on the chipset customer signing a license agreement with terms that the NDRC found to be unreasonable or on the chipset customer not challenging unreasonable terms in its license agreement. The rectification plan does not require the Company to sell chipsets to any entity that is not a patent licensee of the Company.
In addition, the NDRC imposed a fine on the Company of 6.088 billion Chinese Yuan Renminbi (approximately $975 million), which the Company has paid. The Company recorded the amount of the fine in the second quarter of fiscal 2015 as a charge in other expenses.
Federal Trade Commission (FTC) Investigation: On September 17, 2014, the FTC notified the Company that it is conducting an investigation of the Company relating to Section 5 of the Federal Trade Commission Act. The FTC has notified the Company that it is investigating conduct related to standard essential patents and pricing and contracting practices with respect to baseband processors and related products. If a violation of Section 5 is found, a broad range of remedies is potentially available to the FTC, including imposing a fine or requiring modifications to the Company’s business practices. At this stage of the investigation, it is difficult to predict the outcome of this matter or what remedies, if any, may be imposed by the FTC. The Company continues to cooperate with the FTC as it conducts its investigation.
European Commission (Commission) Investigation: On October 15, 2014, the Commission notified the Company that it is conducting an investigation of the Company relating to Article 101 and/or 102 of the Treaty on the Functioning of the European Union (TFEU) and Article 53 and/or 54 of the Agreement for the European Economic Area (EEA Agreement). The Company understands that the investigation concerns the sale and/or marketing of the Company’s baseband chipsets, including alleged conditions relating to the provision by the Company of rebates and/or other financial incentives. If a violation is found, a broad range of remedies is potentially available to the Commission, including imposing a fine and/or injunctive relief prohibiting or restricting certain business practices. Given that this investigation is in its early stages, it is difficult to predict the outcome or what remedies, if any, may be imposed by the Commission. The Company continues to cooperate with the Commission as it conducts its investigation.
Korea Fair Trade Commission (KFTC) Investigation: On March 17, 2015, the KFTC notified the Company that it is conducting an investigation of the Company relating to the Korean Monopoly Regulation and Fair Trade Act (MRFTA). The Company understands that this investigation concerns primarily its licensing business. If a violation of the MRFTA is found, a broad range of remedies is potentially available to the KFTC, including imposing a fine or requiring modifications to the Company’s licensing practices. Given that this investigation is in its early stages, it is difficult to predict the outcome of this matter or what remedies, if any, may be imposed by the KFTC. The Company continues to cooperate with the KFTC as it conducts its investigation.
With the exception of the NDRC matter, which has been resolved, the Company will continue to vigorously defend itself in the foregoing matters. However, litigation and investigations are inherently uncertain. Accordingly, the Company cannot predict the outcome of these matters. The Company has not recorded any accrual at March 29, 2015 for contingent losses associated with these matters based on its belief that losses, while possible, are not probable. Further, any possible range of loss cannot be reasonably estimated at this time. The unfavorable resolution of one or more of these matters could have a material adverse effect on the Company’s business, results of operations, financial condition or cash flows. The Company is engaged in numerous other legal actions not described above arising in the ordinary course of its business and, while there can be no assurance, believes that the ultimate outcome of these other legal actions will not have a material adverse effect on its business, results of operations, financial condition or cash flows.
Indemnifications. The Company generally does not indemnify its customers and licensees for losses sustained from infringement of third-party intellectual property rights. However, the Company is contingently liable under certain product sales, services, license and other agreements to indemnify certain customers against certain types of liability and/or damages arising from qualifying claims of patent, copyright, trademark or trade secret infringement by products or services sold or provided by the Company. The Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by the Company. Through March 29, 2015, the Company has received a number of claims from its direct and indirect customers and other third parties for indemnification under such agreements with respect to alleged infringement of third-party intellectual property rights by its products.
These indemnification arrangements are not initially measured and recognized at fair value because they are deemed to be similar to product warranties in that they relate to claims and/or other actions that could impair the ability of the Company’s direct or indirect customers to use the Company’s products or services. Accordingly, the Company records liabilities resulting from the arrangements when they are probable and can be reasonably estimated. Reimbursements under indemnification arrangements have not been material to the Company’s consolidated financial statements. The Company has not recorded any accrual for contingent liabilities at March 29, 2015 associated with these indemnification arrangements, other than insignificant amounts, based on the Company’s belief that additional liabilities, while possible, are not probable. Further, any possible range of loss cannot be reasonably estimated at this time.
Purchase Obligations. The Company has agreements with suppliers and other parties to purchase inventory, other goods and services and long-lived assets. Obligations under these agreements at March 29, 2015 for the remainder of fiscal 2015 and for each of the subsequent four years from fiscal 2016 through 2019 were approximately $3.2 billion, $1.2 billion, $941 million, $797 million and $733 million, respectively, and $208 million thereafter. Of these amounts, for the remainder of fiscal 2015 and for each of the subsequent four years from fiscal 2016 through 2019, commitments to purchase integrated circuit product inventories comprised $2.5 billion, $994 million, $794 million, $715 million and $665 million, respectively, and $185 million thereafter. Integrated circuit product inventory obligations represent purchase commitments for wafers, die, finished goods and manufacturing services, such as wafer bump, probe, assembly and final test. Under the Company’s manufacturing relationships with its foundry suppliers and assembly and test service providers, cancelation of outstanding purchase commitments is generally allowed but requires payment of costs incurred through the date of cancelation, and in some cases, incremental fees related to capacity underutilization.
Operating Leases. The Company leases certain of its land, facilities and equipment under noncancelable operating leases, with terms ranging from less than one year to 20 years and with provisions in certain leases for cost-of-living increases. Future minimum lease payments for the remainder of fiscal 2015 and for each of the subsequent four years from fiscal 2016 through 2019 are $45 million, $80 million, $61 million, $33 million and $21 million, respectively, and $21 million thereafter.
Segment Information
Segment Information
Note 8 — Segment Information
The Company is organized on the basis of products and services. The Company conducts business primarily through two reportable segments: QCT (Qualcomm CDMA Technologies) and QTL (Qualcomm Technology Licensing), and its QSI (Qualcomm Strategic Initiatives) reportable segment makes strategic investments. The Company also has nonreportable segments, including its QMT (Qualcomm MEMS Technologies), Pixtronix and Small Cells divisions and other wireless technology and service initiatives.
The Company evaluates the performance of its segments based on earnings (loss) before income taxes (EBT) from continuing operations. Segment EBT includes the allocation of certain corporate expenses to the segments, including depreciation and amortization expense related to unallocated corporate assets. Certain income and charges are not allocated to segments in the Company’s management reports because they are not considered in evaluating the segments’ operating performance. Unallocated income and charges include certain net investment income; certain share-based compensation; and certain research and development expenses, selling, general and administrative expenses and other expenses or income that were deemed to be not directly related to the businesses of the segments. Additionally, unallocated charges include recognition of the step-up of inventories to fair value, amortization and impairment of certain intangible assets and certain other acquisition-related charges, and beginning in the first quarter of fiscal 2015, third-party acquisition and integration services costs and certain other items, which may include major restructuring and restructuring-related costs, goodwill and long-lived asset impairment charges and litigation settlements and/or damages. The table below presents revenues and EBT for reportable segments (in millions):
 
QCT
 
QTL
 
QSI
 
Reconciling
Items
 
Total
For the three months ended
 
 
 
 
 
 
 
 
 
March 29, 2015
 
 
 
 
 
 
 
 
 
Revenues
$
4,434

 
$
2,414

 
$

 
$
46

 
$
6,894

EBT
750

 
2,162

 
(32
)
 
(1,341
)
 
1,539

March 30, 2014
 
 
 
 
 
 
 
 
 
Revenues
$
4,243

 
$
2,071

 
$

 
$
53

 
$
6,367

EBT
740

 
1,834

 
(39
)
 
(263
)
 
2,272

 
 
 
 
 
 
 
 
 
 
For the six months ended
 
 
 
 
 
 
 
 
 
March 29, 2015
 
 
 
 
 
 
 
 
 
Revenues
$
9,676

 
$
4,230

 
$

 
$
87

 
$
13,993

EBT
1,896

 
3,741

 
(33
)
 
(1,767
)
 
3,837

March 30, 2014
 
 
 
 
 
 
 
 
 
Revenues
$
8,859

 
$
3,971

 
$

 
$
159

 
$
12,989

EBT
1,646

 
3,504

 
(35
)
 
(1,086
)
 
4,029


Intersegment revenues included in QCT revenues were negligible in all periods presented. All other revenues for reportable segments were from external customers for all periods presented.
Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30, 2014
 
March 29, 2015
 
March 30, 2014
Revenues
 
 
 
 
 
 
 
Nonreportable segments
$
47

 
$
53

 
$
90

 
$
162

Intersegment eliminations
(1
)
 

 
(3
)
 
(3
)
 
$
46

 
$
53

 
$
87

 
$
159

EBT
 
 
 
 
 
 
 
Unallocated cost of equipment and services revenues
$
(74
)
 
$
(75
)
 
$
(152
)
 
$
(148
)
Unallocated research and development expenses
(226
)
 
(217
)
 
(437
)
 
(434
)
Unallocated selling, general and administrative expenses
(100
)
 
(85
)
 
(249
)
 
(210
)
Unallocated other expense
(1,010
)
 

 
(1,079
)
 
(12
)
Unallocated investment income, net
232

 
314

 
462

 
571

Nonreportable segments
(163
)
 
(200
)
 
(311
)
 
(853
)
Intersegment eliminations

 

 
(1
)
 

 
$
(1,341
)
 
$
(263
)
 
$
(1,767
)
 
$
(1,086
)

Unallocated other expense for the six months ended March 29, 2015 included a $975 million charge related to the resolution reached with the NDRC (Note 7) and $104 million in goodwill impairment charges related to two of the Company’s nonreportable segments (Note 11). Nonreportable segments EBT for the six months ended March 30, 2014 included $444 million in impairment charges related to property, plant and equipment (Note 11).
Unallocated acquisition-related expenses were comprised as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30,
2014
 
March 29,
2015
 
March 30,
2014
Cost of equipment and services revenues
$
63

 
$
62

 
$
129

 
$
123

Research and development expenses
3

 
22

 
8

 
23

Selling, general and administrative expenses
13

 
6

 
25

 
13


Segment assets are comprised of accounts receivable and inventories for all reportable segments other than QSI. QSI segment assets include certain marketable securities, notes receivable, wireless spectrum, other investments and all assets of consolidated subsidiaries included in QSI. Total segment assets differ from total assets on a consolidated basis as a result of unallocated corporate assets primarily comprised of certain cash, cash equivalents, marketable securities, property, plant and equipment, deferred tax assets, goodwill, other intangible assets and assets of nonreportable segments. Segment assets and reconciling items were as follows (in millions):
 
March 29,
2015
 
September 28,
2014
QCT
$
3,412

 
$
3,639

QTL
475

 
161

QSI
614

 
484

Reconciling items
42,672

 
44,290

Total consolidated assets
$
47,173

 
$
48,574

Acquisitions
Acquisitions
Note 9 — Acquisitions
In October 2014, the Company announced that it had reached agreement with CSR plc on the terms of a recommended cash offer to acquire the entire issued and to be issued ordinary share capital of CSR for £9.00 per ordinary share, which values the entire issued and to be issued share capital of CSR at approximately £1.6 billion (approximately $2.3 billion based upon an exchange rate of USD: GBP 1.4929). CSR is an innovator in the development of multifunction semiconductor platforms and technologies for the automotive, consumer and voice and music market categories. The acquisition complements the Company’s current offerings by adding products, channels and customers in the growth categories of the Internet of Everything and automotive infotainment, accelerating the Company’s presence and path to leadership. The acquisition has received approval of CSR’s shareholders, and every required regulatory agency has either provided approval or declined to exercise jurisdiction, except for the Ministry of Commerce in China. The completion of the acquisition remains subject to satisfaction of additional conditions. Subject to the satisfaction of these conditions, the acquisition is expected to close by the end of the summer of 2015. In connection with the pending acquisition, the Company agreed to set aside certain cash, cash equivalents and marketable securities (Note 12).
Discontinued Operations
Discontinued Operations
Note 10 — Discontinued Operations
On November 25, 2013, the Company completed its sale of the North and Latin America operations of its Omnitracs division to a U.S.-based private equity firm for cash consideration of $788 million (net of cash sold). As a result, the Company recorded a gain in discontinued operations of $665 million ($430 million net of income tax expense) during fiscal 2014. The revenues and operating results of the North and Latin America operations of the Omnitracs division, which comprised substantially all of the Omnitracs division, were not presented as discontinued operations in any fiscal period because they were immaterial.
Fair Value Measurements
Fair Value Measurements
Note 11 — Fair Value Measurements
The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 29, 2015 (in millions):
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash equivalents
$
2,453

 
$
2,751

 
$

 
$
5,204

Marketable securities (a)
 
 
 
 
 
 
 
U.S. Treasury securities and government-related securities
252

 
1,209

 

 
1,461

Corporate bonds and notes

 
15,440

 

 
15,440

Mortgage- and asset-backed securities

 
1,355

 
181

 
1,536

Auction rate securities

 

 
47

 
47

Common and preferred stock
676

 
715

 

 
1,391

Equity funds
646

 

 

 
646

Debt funds

 
3,597

 

 
3,597

Total marketable securities
1,574

 
22,316

 
228

 
24,118

Derivative instruments
1

 
6

 

 
7

Other investments (a)
318

 

 

 
318

Total assets measured at fair value
$
4,346

 
$
25,073

 
$
228

 
$
29,647

Liabilities
 
 
 
 
 
 
 
Derivative instruments
$
2

 
$
4

 
$

 
$
6

Other liabilities
294

 

 

 
294

Total liabilities measured at fair value
$
296

 
$
4

 
$

 
$
300


(a) Included amounts that are restricted (Note 12).
Activity between Levels of the Fair Value Hierarchy. There were no significant transfers between Level 1 and Level 2 during the six months ended March 29, 2015 or March 30, 2014. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. The following table includes the activity for marketable securities classified within Level 3 of the valuation hierarchy (in millions):
 
Six Months Ended
March 29, 2015
 
Six Months Ended
March 30, 2014
 
Auction Rate
Securities
 
Mortgage- and Asset-Backed
Securities
 
Auction Rate
Securities
 
Mortgage- and Asset-Backed
Securities
Beginning balance of Level 3
$
83

 
$
186

 
$
83

 
$
239

Total realized and unrealized gains or losses:
 
 
 
 
 
 
 
Included in investment income, net

 
3

 

 
3

Included in other comprehensive income

 
(4
)
 

 
1

Purchases

 
50

 

 
49

Sales

 
(41
)
 

 
(18
)
Settlements
(36
)
 
(13
)
 

 
(22
)
Transfers out of Level 3

 

 

 
(2
)
Ending balance of Level 3
$
47

 
$
181

 
$
83

 
$
250


The Company recognizes transfers into and out of levels within the fair value hierarchy at the end of the fiscal month in which the actual event or change in circumstances that caused the transfer occurs. There were no transfers in or out of Level 3 during the six months ended March 29, 2015. Transfers out of Level 3 during the six months ended March 30, 2014 primarily consisted of debt securities with significant upgrades in credit ratings.
Nonrecurring Fair Value Measurements. The Company measures certain assets at fair value on a nonrecurring basis. These assets include cost and equity method investments when they are deemed to be other-than-temporarily impaired, assets acquired and liabilities assumed in an acquisition or in a nonmonetary exchange, and property, plant and equipment and intangible assets that are written down to fair value when they are held for sale or determined to be impaired. During the six months ended March 29, 2015, the Company updated the business plans and related internal forecasts related to the Company’s push-to-talk services business and its display businesses, resulting in impairment charges of $104 million related to goodwill and $27 million related to in-process research and development (IPR&D). During the six months ended March 30, 2014, the Company recorded impairment charges of $444 million to write down certain property, plant and equipment related to one of the Company’s display businesses and $16 million related to goodwill in its former QRS division. The IPR&D impairment charge was recorded in research and development expenses, and the other impairment charges were recorded in other operating expenses. The Company determined the fair values using cost, income and market approaches. The estimation of fair value and cash flows used in the fair value measurements required the use of significant unobservable inputs, and as a result, the fair value measurements were classified as Level 3. During the six months ended March 29, 2015 and March 30, 2014, the Company did not have any other significant assets or liabilities that were measured at fair value on a nonrecurring basis in periods subsequent to initial recognition.
Marketable Securities
Marketable Securities
Note 12 — Marketable Securities
Marketable securities were comprised as follows (in millions):
 
Current
 
Noncurrent
 
March 29,
2015
 
September 28,
2014
 
March 29,
2015
 
September 28,
2014
Trading:
 
 
 
 
 
 
 
U.S. Treasury securities and government-related securities
$
338

 
$
320

 
$
23

 
$
38

Corporate bonds and notes
177

 
191

 
345

 
367

Mortgage- and asset-backed securities

 

 
240

 
237

Total trading
515

 
511

 
608

 
642

Available-for-sale:
 
 
 
 
 
 
 
U.S. Treasury securities and government-related securities
385

 
805

 
715

 
392

Corporate bonds and notes
7,250

 
6,274

 
7,668

 
7,649

Mortgage- and asset-backed securities
1,091

 
1,063

 
205

 
195

Auction rate securities

 

 
47

 
83

Common and preferred stock
572

 
192

 
819

 
1,605

Equity funds

 

 
646

 
541

Debt funds
250

 
813

 
2,559

 
2,560

Total available-for-sale
9,548

 
9,147

 
12,659

 
13,025

Fair value option:
 
 
 
 
 
 
 
Debt fund

 

 
788

 
790

Total marketable securities
$
10,063

 
$
9,658

 
$
14,055

 
$
14,457


In connection with the pending acquisition of CSR (Note 9), the Company agreed to set aside certain cash, cash equivalents and marketable securities to be held for purposes of satisfying payment of the consideration to effect the acquisition, which is expected to close by the end of the summer of 2015. At March 29, 2015, the fair values of the marketable securities that were set aside were $2.9 billion of corporate bonds and notes, $717 million of mortgage- and asset-backed securities and $140 million in U.S. Treasury securities and government-related securities. Additionally, $24 million in cash equivalents, which were recorded as other current assets, were set aside. If the combined fair values fall below approximately £1.9 billion (approximately $2.8 billion using an exchange rate of 1.4929), the Company may be required to set aside additional amounts. Additionally, if certain conditions are met, such as a reduction in the liquidity of any of the securities that are set aside, the Company may be required to liquidate the securities and transfer the cash to a third party until the acquisition closes.
The Company holds an investment in a debt fund for which the Company elected the fair value option because the Company is able to redeem its shares at net asset value, which is determined daily. The investment would have otherwise been recorded using the equity method. The debt fund has no single maturity date. At March 29, 2015, the Company had an effective ownership interest in the debt fund of 27%. Changes in fair value associated with this investment are recognized in net investment income. During the three and six months ended March 29, 2015, the changes in fair value associated with this investment were negligible. During the three and six months ended March 30, 2014, net increases in fair value associated with this investment were $12 million and $18 million, respectively.
The Company classifies certain portfolios of debt securities that utilize derivative instruments to acquire or reduce foreign exchange, interest rate and/or equity, prepayment and credit risks as trading. Net gains recognized on debt securities classified as trading held at March 29, 2015 were $14 million and negligible for the three and six months ended March 29, 2015, respectively. Net gains recognized on debt securities classified as trading held at March 30, 2014 were negligible for both the three and six months ended March 30, 2014.
At March 29, 2015, the contractual maturities of available-for-sale debt securities were as follows (in millions):
Years to Maturity
 
 
 
 
Less Than
One Year
 
One to
Five Years
 
Five to
Ten Years
 
Greater Than
Ten Years
 
No Single
Maturity
Date
 
Total
$
2,818

 
$
11,245

 
$
1,363

 
$
592

 
$
4,152

 
$
20,170


Debt securities with no single maturity date included debt funds, mortgage- and asset-backed securities, auction rate securities and corporate bonds and notes.
The Company recorded realized gains and losses on sales of available-for-sale securities as follows (in millions):
 
Gross Realized Gains
 
Gross Realized Losses
 
Net Realized Gains
For the three months ended
 
 
 
 
 
March 29, 2015
$
128

 
$
(30
)
 
$
98

March 30, 2014
227

 
(5
)
 
222

 
 
 
 
 
 
For the six months ended
 
 
 
 
 
March 29, 2015
$
308

 
$
(37
)
 
$
271

March 30, 2014
343

 
(8
)
 
335


Available-for-sale securities were comprised as follows (in millions):
 
Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value
March 29, 2015
 
 
 
 
 
 
 
Equity securities
$
1,654

 
$
383

 
$

 
$
2,037

Debt securities (including debt funds)
19,940

 
311

 
(81
)
 
20,170

 
$
21,594

 
$
694

 
$
(81
)
 
$
22,207

September 28, 2014
 
 
 
 
 
 
 
Equity securities
$
1,769

 
$
575

 
$
(6
)
 
$
2,338

Debt securities (including debt funds)
19,582

 
312

 
(60
)
 
19,834

 
$
21,351

 
$
887

 
$
(66
)
 
$
22,172


The following table shows the gross unrealized losses and fair values of the Company’s investments in individual securities that are classified as available-for-sale and have been in a continuous unrealized loss position deemed to be temporary for less than 12 months and for more than 12 months, aggregated by investment category (in millions):
 
March 29, 2015
 
Less than 12 months
 
More than 12 months
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
U.S. Treasury securities and government-related securities
$
395

 
$
(3
)
 
$

 
$

Corporate bonds and notes
4,211

 
(58
)
 
201

 
(10
)
Mortgage- and asset-backed securities
535

 
(1
)
 
26

 

Auction rate securities

 

 
47

 
(1
)
Common and preferred stock
13

 

 
12

 

Debt funds
784

 
(7
)
 
38

 
(1
)
 
$
5,938

 
$
(69
)
 
$
324

 
$
(12
)
 
September 28, 2014
 
Less than 12 months
 
More than 12 months
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
U.S. Treasury securities and government-related securities
$
279

 
$
(2
)
 
$

 
$

Corporate bonds and notes
4,924

 
(31
)
 
104

 
(4
)
Mortgage- and asset-backed securities
484

 
(1
)
 
52

 
(1
)
Auction rate securities

 

 
83

 
(1
)
Common and preferred stock
86

 
(3
)
 
52

 
(3
)
Debt funds
133

 
(1
)
 
384

 
(19
)
 
$
5,906

 
$
(38
)
 
$
675

 
$
(28
)

At March 29, 2015, the Company concluded that the unrealized losses on its available-for-sale securities were temporary. Further, for common stock and for equity and debt funds with unrealized losses, the Company has the ability and the intent to hold such securities until they recover, which is expected to be within a reasonable period of time. For debt securities and preferred stock with unrealized losses, the Company does not have the intent to sell, nor is it more likely than not that the Company will be required to sell, such securities before recovery or maturity.
The ending balance of the credit loss portion of other-than-temporary impairments on debt securities held by the Company was negligible at March 29, 2015 and March 30, 2014.
Basis of Presentation (Policies)
The Company operates and reports using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three-month and six-month periods ended March 29, 2015 and March 30, 2014 included 13 weeks and 26 weeks, respectively.
Basic earnings per common share are computed by dividing net income attributable to Qualcomm by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per common share are computed by dividing net income attributable to Qualcomm by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans and shares subject to written put options, if any, and the weighted-average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money share equivalents, which are calculated based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an award, if any, the amount of compensation cost for future service that the Company has not yet recognized, if any, and the estimated tax benefits that would be recorded in paid-in capital when an award is settled, if any, are assumed to be used to repurchase shares in the current period. The dilutive common share equivalents, calculated using the treasury stock method, for the three and six months ended March 29, 2015 were 21,588,000 and 23,295,000, respectively. The dilutive common share equivalents, calculated using the treasury stock method, for the three and six months ended March 30, 2014 were 30,989,000 and 32,656,000, respectively. Shares of common stock equivalents outstanding that were not included in the computation of diluted earnings per common share because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period were 18,000 and 744,000 during the three and six months ended March 29, 2015, respectively, and 12,000 and 413,000 during the three and six months ended March 30, 2014, respectively
Recent Accounting Pronouncements. In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers,” which outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. The new standard requires a company to recognize revenue upon transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. ASU 2014-09 defines a five-step approach for recognizing revenue, which may require a company to use more judgment and make more estimates than under the current guidance. The ASU as currently issued will be effective for the Company starting in the first quarter of fiscal 2018. On April 1, 2015, the FASB voted to propose a one-year deferral to the effective date, but to permit entities to adopt one year earlier if they choose (i.e., the original effective date). The proposal will be subject to the FASB’s due process requirement, which includes a period for public comments. The new standard allows for two methods of adoption: (a) full retrospective adoption, meaning the standard is applied to all periods presented, or (b) modified retrospective adoption, meaning the cumulative effect of applying the new standard is recognized as an adjustment to the opening retained earnings balance. The Company is in the process of determining the adoption method as well as the effects the adoption will have on its consolidated financial statements.
Marketable Securities (Policies)
Marketable Securities, Trading Securities
The Company classifies certain portfolios of debt securities that utilize derivative instruments to acquire or reduce foreign exchange, interest rate and/or equity, prepayment and credit risks as trading
Basis of Presentation (Tables)
Share-based compensation expense, related to all share-based awards
Total share-based compensation expense, related to all of the Company’s share-based awards, was comprised as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30,
2014
 
March 29,
2015
 
March 30,
2014
Cost of equipment and services revenues
$
11

 
$
13

 
$
23

 
$
25

Research and development
158

 
163

 
333

 
336

Selling, general and administrative
80

 
75

 
166

 
171

Share-based compensation expense before income taxes
249

 
251

 
522

 
532

Related income tax benefit
(43
)
 
(53
)
 
(86
)
 
(109
)
 
$
206

 
$
198

 
$
436

 
$
423

Composition of Certain Financial Statement Items (Tables)
Accounts Receivable (in millions)
 
 
 
 
March 29,
2015
 
September 28,
2014
Trade, net of allowances for doubtful accounts of $5 and $5, respectively
$
2,040

 
$
2,362

Long-term contracts
11

 
17

Other
7

 
33

 
$
2,058

 
$
2,412

Inventories (in millions)
 
 
 
 
March 29,
2015
 
September 28,
2014
Raw materials
$
1

 
$
1

Work-in-process
903

 
656

Finished goods
957

 
801

 
$
1,861

 
$
1,458

Other Current Liabilities (in millions)
 
 
 
 
March 29,
2015
 
September 28,
2014
Customer incentives and other customer-related liabilities
$
1,452

 
$
1,777

Other
416

 
466

 
$
1,868

 
$
2,243

Investment Income, Net (Tables)
Investment Income, Net
Investment Income, Net (in millions)
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30,
2014
 
March 29,
2015
 
March 30,
2014
Interest and dividend income
$
138

 
$
167

 
$
272

 
$
322

Interest expense
(1
)
 
(3
)
 
(2
)
 
(5
)
Net realized gains on marketable securities
108

 
243

 
264

 
371

Net realized gains on other investments
3

 

 
13

 
17

Impairment losses on marketable securities
(27
)
 
(112
)
 
(89
)
 
(141
)
Impairment losses on other investments
(14
)
 
(11
)
 
(17
)
 
(18
)
Net gains on derivative instruments
2

 

 
6

 
4

Equity in net losses of investees
(9
)
 
(4
)
 
(13
)
 
(5
)
Net gains on deconsolidation of subsidiaries
3

 
2

 
3

 
1

 
$
203

 
$
282

 
$
437

 
$
546

Stockholders' Equity (Tables)
Changes in stockholders’ equity for the six months ended March 29, 2015 were as follows (in millions):
 
Qualcomm Stockholders’ Equity
 
Noncontrolling Interests
 
Total Stockholders’ Equity
Balance at September 28, 2014
$
39,169

 
$
(3
)
 
$
39,166

Net income (loss)
3,025

 
(2
)
 
3,023

  Other comprehensive loss
(162
)
 

 
(162
)
Common stock issued under employee benefit plans and related tax benefits
476

 

 
476

Share-based compensation
548

 

 
548

Tax withholding related to vesting of restricted stock units
(193
)
 

 
(193
)
Dividends
(1,412
)
 

 
(1,412
)
Stock repurchases
(3,611
)
 

 
(3,611
)
Other
(1
)
 

 
(1
)
Balance at March 29, 2015
$
37,839

 
$
(5
)
 
$
37,834

Accumulated Other Comprehensive Income. Changes in the components of accumulated other comprehensive income, net of income taxes, in Qualcomm stockholders’ equity during the six months ended March 29, 2015 were as follows (in millions):
 
Foreign Currency Translation Adjustment
 
Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities
 
Net Unrealized Gain (Loss) on Other Available-for-Sale Securities
 
Total Accumulated Other Comprehensive Income
Balance at September 28, 2014
$
(113
)
 
$
24

 
$
723

 
$
634

Other comprehensive loss before reclassifications
(31
)
 
(7
)
 
(6
)
 
(44
)
Reclassifications from accumulated other comprehensive income

 
4

 
(122
)
 
(118
)
Other comprehensive loss
(31
)
 
(3
)
 
(128
)
 
(162
)
Balance at March 29, 2015
$
(144
)
 
$
21

 
$
595

 
$
472

During the six months ended March 29, 2015 and March 30, 2014, dividends charged to retained earnings were as follows (in millions, except per share data):
 
2015
 
2014
 
Per Share
 
Total
 
Per Share
 
Total
First quarter
$
0.42

 
$
710

 
$
0.35

 
$
599

Second quarter
0.42

 
702

 
0.35

 
599

 
$
0.84

 
$
1,412

 
$
0.70

 
$
1,198

Segment Information (Tables)
The table below presents revenues and EBT for reportable segments (in millions):
 
QCT
 
QTL
 
QSI
 
Reconciling
Items
 
Total
For the three months ended
 
 
 
 
 
 
 
 
 
March 29, 2015
 
 
 
 
 
 
 
 
 
Revenues
$
4,434

 
$
2,414

 
$

 
$
46

 
$
6,894

EBT
750

 
2,162

 
(32
)
 
(1,341
)
 
1,539

March 30, 2014
 
 
 
 
 
 
 
 
 
Revenues
$
4,243

 
$
2,071

 
$

 
$
53

 
$
6,367

EBT
740

 
1,834

 
(39
)
 
(263
)
 
2,272

 
 
 
 
 
 
 
 
 
 
For the six months ended
 
 
 
 
 
 
 
 
 
March 29, 2015
 
 
 
 
 
 
 
 
 
Revenues
$
9,676

 
$
4,230

 
$

 
$
87

 
$
13,993

EBT
1,896

 
3,741

 
(33
)
 
(1,767
)
 
3,837

March 30, 2014
 
 
 
 
 
 
 
 
 
Revenues
$
8,859

 
$
3,971

 
$

 
$
159

 
$
12,989

EBT
1,646

 
3,504

 
(35
)
 
(1,086
)
 
4,029

Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30, 2014
 
March 29, 2015
 
March 30, 2014
Revenues
 
 
 
 
 
 
 
Nonreportable segments
$
47

 
$
53

 
$
90

 
$
162

Intersegment eliminations
(1
)
 

 
(3
)
 
(3
)
 
$
46

 
$
53

 
$
87

 
$
159

EBT
 
 
 
 
 
 
 
Unallocated cost of equipment and services revenues
$
(74
)
 
$
(75
)
 
$
(152
)
 
$
(148
)
Unallocated research and development expenses
(226
)
 
(217
)
 
(437
)
 
(434
)
Unallocated selling, general and administrative expenses
(100
)
 
(85
)
 
(249
)
 
(210
)
Unallocated other expense
(1,010
)
 

 
(1,079
)
 
(12
)
Unallocated investment income, net
232

 
314

 
462

 
571

Nonreportable segments
(163
)
 
(200
)
 
(311
)
 
(853
)
Intersegment eliminations

 

 
(1
)
 

 
$
(1,341
)
 
$
(263
)
 
$
(1,767
)
 
$
(1,086
)
Reconciling items in the previous table were as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30, 2014
 
March 29, 2015
 
March 30, 2014
Revenues
 
 
 
 
 
 
 
Nonreportable segments
$
47

 
$
53

 
$
90

 
$
162

Intersegment eliminations
(1
)
 

 
(3
)
 
(3
)
 
$
46

 
$
53

 
$
87

 
$
159

EBT
 
 
 
 
 
 
 
Unallocated cost of equipment and services revenues
$
(74
)
 
$
(75
)
 
$
(152
)
 
$
(148
)
Unallocated research and development expenses
(226
)
 
(217
)
 
(437
)
 
(434
)
Unallocated selling, general and administrative expenses
(100
)
 
(85
)
 
(249
)
 
(210
)
Unallocated other expense
(1,010
)
 

 
(1,079
)
 
(12
)
Unallocated investment income, net
232

 
314

 
462

 
571

Nonreportable segments
(163
)
 
(200
)
 
(311
)
 
(853
)
Intersegment eliminations

 

 
(1
)
 

 
$
(1,341
)
 
$
(263
)
 
$
(1,767
)
 
$
(1,086
)
Unallocated acquisition-related expenses were comprised as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
March 29,
2015
 
March 30,
2014
 
March 29,
2015
 
March 30,
2014
Cost of equipment and services revenues
$
63

 
$
62

 
$
129

 
$
123

Research and development expenses
3

 
22

 
8

 
23

Selling, general and administrative expenses
13

 
6

 
25

 
13

Segment assets and reconciling items were as follows (in millions):
 
March 29,
2015
 
September 28,
2014
QCT
$
3,412

 
$
3,639

QTL
475

 
161

QSI
614

 
484

Reconciling items
42,672

 
44,290

Total consolidated assets
$
47,173

 
$
48,574

Fair Value Measurements (Tables)
The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 29, 2015 (in millions):
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
Cash equivalents
$
2,453

 
$
2,751

 
$

 
$
5,204

Marketable securities (a)
 
 
 
 
 
 
 
U.S. Treasury securities and government-related securities
252

 
1,209

 

 
1,461

Corporate bonds and notes

 
15,440

 

 
15,440

Mortgage- and asset-backed securities

 
1,355

 
181

 
1,536

Auction rate securities

 

 
47

 
47

Common and preferred stock
676

 
715

 

 
1,391

Equity funds
646

 

 

 
646

Debt funds

 
3,597

 

 
3,597

Total marketable securities
1,574

 
22,316

 
228

 
24,118

Derivative instruments
1

 
6

 

 
7

Other investments (a)
318

 

 

 
318

Total assets measured at fair value
$
4,346

 
$
25,073

 
$
228

 
$
29,647

Liabilities
 
 
 
 
 
 
 
Derivative instruments
$
2

 
$
4

 
$

 
$
6

Other liabilities
294

 

 

 
294

Total liabilities measured at fair value
$
296

 
$
4

 
$

 
$
300


(a) Included amounts that are restricted (Note 12).
The following table includes the activity for marketable securities classified within Level 3 of the valuation hierarchy (in millions):
 
Six Months Ended
March 29, 2015
 
Six Months Ended
March 30, 2014
 
Auction Rate
Securities
 
Mortgage- and Asset-Backed
Securities
 
Auction Rate
Securities
 
Mortgage- and Asset-Backed
Securities
Beginning balance of Level 3
$
83

 
$
186

 
$
83

 
$
239

Total realized and unrealized gains or losses:
 
 
 
 
 
 
 
Included in investment income, net

 
3

 

 
3

Included in other comprehensive income

 
(4
)
 

 
1

Purchases

 
50

 

 
49

Sales

 
(41
)
 

 
(18
)
Settlements
(36
)
 
(13
)
 

 
(22
)
Transfers out of Level 3

 

 

 
(2
)
Ending balance of Level 3
$
47

 
$
181

 
$
83

 
$
250


Marketable Securities (Tables)
Marketable securities were comprised as follows (in millions):
 
Current
 
Noncurrent
 
March 29,
2015
 
September 28,
2014
 
March 29,
2015
 
September 28,
2014
Trading:
 
 
 
 
 
 
 
U.S. Treasury securities and government-related securities
$
338

 
$
320

 
$
23

 
$
38

Corporate bonds and notes
177

 
191

 
345

 
367

Mortgage- and asset-backed securities

 

 
240

 
237

Total trading
515

 
511

 
608

 
642

Available-for-sale:
 
 
 
 
 
 
 
U.S. Treasury securities and government-related securities
385

 
805

 
715

 
392

Corporate bonds and notes
7,250

 
6,274

 
7,668

 
7,649

Mortgage- and asset-backed securities
1,091

 
1,063

 
205

 
195

Auction rate securities

 

 
47

 
83

Common and preferred stock
572

 
192

 
819

 
1,605

Equity funds

 

 
646

 
541

Debt funds
250

 
813

 
2,559

 
2,560

Total available-for-sale
9,548

 
9,147

 
12,659

 
13,025

Fair value option:
 
 
 
 
 
 
 
Debt fund

 

 
788

 
790

Total marketable securities
$
10,063

 
$
9,658

 
$
14,055

 
$
14,457

At March 29, 2015, the contractual maturities of available-for-sale debt securities were as follows (in millions):
Years to Maturity
 
 
 
 
Less Than
One Year
 
One to
Five Years
 
Five to
Ten Years
 
Greater Than
Ten Years
 
No Single
Maturity
Date
 
Total
$
2,818

 
$
11,245

 
$
1,363

 
$
592

 
$
4,152

 
$
20,170

The Company recorded realized gains and losses on sales of available-for-sale securities as follows (in millions):
 
Gross Realized Gains
 
Gross Realized Losses
 
Net Realized Gains
For the three months ended
 
 
 
 
 
March 29, 2015
$
128

 
$
(30
)
 
$
98

March 30, 2014
227

 
(5
)
 
222

 
 
 
 
 
 
For the six months ended
 
 
 
 
 
March 29, 2015
$
308

 
$
(37
)
 
$
271

March 30, 2014
343

 
(8
)
 
335

Available-for-sale securities were comprised as follows (in millions):
 
Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value
March 29, 2015
 
 
 
 
 
 
 
Equity securities
$
1,654

 
$
383

 
$

 
$
2,037

Debt securities (including debt funds)
19,940

 
311

 
(81
)
 
20,170

 
$
21,594

 
$
694

 
$
(81
)
 
$
22,207

September 28, 2014
 
 
 
 
 
 
 
Equity securities
$
1,769

 
$
575

 
$
(6
)
 
$
2,338

Debt securities (including debt funds)
19,582

 
312

 
(60
)
 
19,834

 
$
21,351

 
$
887

 
$
(66
)
 
$
22,172

The following table shows the gross unrealized losses and fair values of the Company’s investments in individual securities that are classified as available-for-sale and have been in a continuous unrealized loss position deemed to be temporary for less than 12 months and for more than 12 months, aggregated by investment category (in millions):
 
March 29, 2015
 
Less than 12 months
 
More than 12 months
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
U.S. Treasury securities and government-related securities
$
395

 
$
(3
)
 
$

 
$

Corporate bonds and notes
4,211

 
(58
)
 
201

 
(10
)
Mortgage- and asset-backed securities
535

 
(1
)
 
26

 

Auction rate securities

 

 
47

 
(1
)
Common and preferred stock
13

 

 
12

 

Debt funds
784

 
(7
)
 
38

 
(1
)
 
$
5,938

 
$
(69
)
 
$
324

 
$
(12
)
 
September 28, 2014
 
Less than 12 months
 
More than 12 months
 
Fair Value
 
Unrealized Losses
 
Fair Value
 
Unrealized Losses
U.S. Treasury securities and government-related securities
$
279

 
$
(2
)
 
$

 
$

Corporate bonds and notes
4,924

 
(31
)
 
104

 
(4
)
Mortgage- and asset-backed securities
484

 
(1
)
 
52

 
(1
)
Auction rate securities

 

 
83

 
(1
)
Common and preferred stock
86

 
(3
)
 
52

 
(3
)
Debt funds
133

 
(1
)
 
384

 
(19
)
 
$
5,906

 
$
(38
)
 
$
675

 
$
(28
)
Basis of Presentation Earnings Per Common Share (Details)
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Incremental Dilutive Common Share Equivalents [Abstract]
 
 
 
 
Dilutive common share equivalents
21,588,000 
30,989,000 
23,295,000 
32,656,000 
Common share equivalents excluded from computation of diluted EPS
18,000 
12,000 
744,000 
413,000 
Basis of Presentation Share-Based Compensation Expense (Details) (USD $)
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
Share-based compensation expense before income taxes
$ 249,000,000 
$ 251,000,000 
$ 522,000,000 
$ 532,000,000 
Related income tax benefit
(43,000,000)
(53,000,000)
(86,000,000)
(109,000,000)
Share-based compensation expense, net of income taxes
206,000,000 
198,000,000 
436,000,000 
423,000,000 
Share-based compensation expense related to share-based awards granted during period
 
 
81,000,000 
82,000,000 
Cost of equipment and services revenues
 
 
 
 
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
Share-based compensation expense before income taxes
11,000,000 
13,000,000 
23,000,000 
25,000,000 
Research and development
 
 
 
 
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
Share-based compensation expense before income taxes
158,000,000 
163,000,000 
333,000,000 
336,000,000 
Selling, general and administrative
 
 
 
 
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
Share-based compensation expense before income taxes
80,000,000 
75,000,000 
166,000,000 
171,000,000 
Restricted Stock [Member]
 
 
 
 
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
Unrecognized compensation costs related to non-vested restricted stock units
$ 1,300,000,000 
 
$ 1,300,000,000 
 
Weighted average period over which unrecognized compensation expense related to nonvested restricted stock units is expected to be recognized
 
 
1 year 10 months 
 
Equity Compensation Plans Consolidated [Member]
 
 
 
 
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
Net share based awards granted in fiscal year as percent of total outstanding stock at beginning of fiscal period
0.40% 
0.40% 
0.40% 
0.40% 
Total share based awards granted in fiscal year as percent of total outstanding stock at end of fiscal period
0.50% 
0.50% 
0.50% 
0.50% 
Composition of Certain Financial Statement Items Accounts Receivable (Details) (USD $)
In Millions, unless otherwise specified
Mar. 29, 2015
Sep. 28, 2014
Accounts Receivable [Abstract]
 
 
Allowance for Doubtful Accounts Receivable
$ 5 
$ 5 
Trade, net of allowances for doubtful accounts
2,040 
2,362 
Long-term contracts
11 
17 
Other
33 
Accounts receivable, net
$ 2,058 
$ 2,412 
Composition of Certain Financial Statement Items Inventories (Details) (USD $)
In Millions, unless otherwise specified
Mar. 29, 2015
Sep. 28, 2014
Inventory, Net [Abstract]
 
 
Raw materials
$ 1 
$ 1 
Work-in-process
903 
656 
Finished goods
957 
801 
Inventories
$ 1,861 
$ 1,458 
Composition of Certain Financial Statement Items Other Current Liabilities (Details) (USD $)
In Millions, unless otherwise specified
Mar. 29, 2015
Sep. 28, 2014
Other Liabilities, Current [Abstract]
 
 
Customer incentives and other customer-related liabilities
$ 1,452 
$ 1,777 
Other
416 
466 
Other current liabilities
$ 1,868 
$ 2,243 
Investment Income, Net (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Investment Income, Net [Abstract]
 
 
 
 
Interest and dividend income
$ 138 
$ 167 
$ 272 
$ 322 
Interest expense
(1)
(3)
(2)
(5)
Net realized gains on marketable securities
108 
243 
264 
371 
Net realized gains on other investments
13 
17 
Impairment losses on marketable securities
(27)
(112)
(89)
(141)
Impairment losses on other investments
(14)
(11)
(17)
(18)
Net gains on derivative instruments
Equity in net losses of investees
(9)
(4)
(13)
(5)
Net gains on deconsolidation of subsidiaries
Investment income, net
$ 203 
$ 282 
$ 437 
$ 546 
Income Taxes (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended
Mar. 29, 2015
Dec. 28, 2014
Sep. 28, 2014
Sep. 27, 2015
Scenario, Forecast [Member]
Mar. 29, 2015
United States of America, Dollars
Mar. 29, 2015
United States of America, Dollars
UnallocatedOtherIncome [Member]
Income Tax Disclosure [Abstract]
 
 
 
 
 
 
Effective income tax rate for continuing operations
32.00% 
 
14.00% 
21.00% 
 
 
Tax benefits from foreign income taxed at rates lower than rates in the United States
 
 
20.00% 
17.00% 
 
 
Resolution of governmental investigation, Amount
 
 
 
 
$ 975 
$ 975 
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
61 
 
 
 
 
 
Tax Benefit Recognized In Period Related To Prior Period Attributable To Research and Development Tax Credit
 
$ 101 
 
 
 
 
Stockholders' Equity Changes in Stockholders' Equity (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Dec. 28, 2014
Mar. 30, 2014
Dec. 29, 2013
Mar. 29, 2015
Mar. 30, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]
 
 
 
 
 
 
Balance at beginning of period
 
$ 39,166 
 
 
$ 39,166 
 
Net income attributable to Qualcomm
1,053 
 
1,959 
 
3,025 
3,835 
Net loss attributable to noncontrolling interests
(1)
 
(1)
 
(2)
(2)
Net income
1,052 
 
1,958 
 
3,023 
3,833 
Other comprehensive loss
44 
 
25 
 
(162)
57 
Common stock issued under employee benefit plans and related tax benefits
 
 
 
 
476 
 
Share-based compensation
 
 
 
 
548 
 
Tax withholding related to vesting of restricted stock units
 
 
 
 
(193)
 
Dividends
(702)
(710)
(599)
(599)
(1,412)
(1,198)
Stock repurchases
 
 
 
 
(3,611)
 
Other
 
 
 
 
(1)
 
Balance at end of period
37,834 
 
 
 
37,834 
 
Qualcomm Stockholders' Equity [Member]
 
 
 
 
 
 
Increase (Decrease) in Stockholders' Equity [Roll Forward]
 
 
 
 
 
 
Balance at beginning of period
 
39,169 
 
 
39,169 
 
Net income attributable to Qualcomm
 
 
 
 
3,025 
 
Other comprehensive loss attributable to Qualcomm
 
 
 
 
(162)
 
Common stock issued under employee benefit plans and related tax benefits
 
 
 
 
476 
 
Share-based compensation
 
 
 
 
548 
 
Tax withholding related to vesting of restricted stock units
 
 
 
 
(193)
 
Dividends
 
 
 
 
(1,412)
 
Stock repurchases
 
 
 
 
(3,611)
 
Other
 
 
 
 
(1)
 
Balance at end of period
37,839 
 
 
 
37,839 
 
Noncontrolling Interests [Member]
 
 
 
 
 
 
Increase (Decrease) in Stockholders' Equity [Roll Forward]
 
 
 
 
 
 
Balance at beginning of period
 
(3)
 
 
(3)
 
Net loss attributable to noncontrolling interests
 
 
 
 
(2)
 
Other comprehensive loss attributable to noncontrolling Interests
 
 
 
 
 
Common stock issued under employee benefit plans and related tax benefits
 
 
 
 
 
Share-based compensation
 
 
 
 
 
Tax withholding related to vesting of restricted stock units
 
 
 
 
 
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
 
 
 
 
 
Stock repurchases
 
 
 
 
 
Other
 
 
 
 
 
Balance at end of period
$ (5)
 
 
 
$ (5)
 
Stockholders' Equity Accumulated Other Comprehensive Income (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Beginning balance total accumulated other comprehensive income
 
 
$ 634 
 
Ending balance total accumulated other comprehensive income
472 
 
472 
 
Investment income, net
203 
282 
437 
546 
Reclassifications from Accumulated Other Comprehensive Income [Member]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Investment income, net
47 
71 
118 
124 
Foreign Currency Translation Adjustment [Member]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Beginning balance total accumulated other comprehensive income
 
 
(113)
 
Other comprehensive loss before reclassifications
 
 
(31)
 
Reclassifications from accumulated other comprehensive income
 
 
 
Other comprehensive loss
 
 
(31)
 
Ending balance total accumulated other comprehensive income
(144)
 
(144)
 
Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities [Member]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Beginning balance total accumulated other comprehensive income
 
 
24 
 
Other comprehensive loss before reclassifications
 
 
(7)
 
Reclassifications from accumulated other comprehensive income
 
 
 
Other comprehensive loss
 
 
(3)
 
Ending balance total accumulated other comprehensive income
21 
 
21 
 
Net Unrealized Gain (Loss) on Other Available-for-Sale Securities [Member]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Beginning balance total accumulated other comprehensive income
 
 
723 
 
Other comprehensive loss before reclassifications
 
 
(6)
 
Reclassifications from accumulated other comprehensive income
 
 
(122)
 
Other comprehensive loss
 
 
(128)
 
Ending balance total accumulated other comprehensive income
595 
 
595 
 
Net Unrealized Gain (Loss) on Derivative Instruments [Member] |
Reclassifications from Accumulated Other Comprehensive Income [Member]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Revenues Costs And Expenses
 
 
13 
Total Accumulated Other Comprehensive Income Attributable to Qualcomm [Member]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
 
 
 
 
Beginning balance total accumulated other comprehensive income
 
 
634 
 
Other comprehensive loss before reclassifications
 
 
(44)
 
Reclassifications from accumulated other comprehensive income
 
 
(118)
 
Other comprehensive loss
 
 
(162)
 
Ending balance total accumulated other comprehensive income
$ 472 
 
$ 472 
 
Stockholders' Equity (Details) (USD $)
6 Months Ended 1 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 9, 2015
Apr. 22, 2015
Subsequent Event
Mar. 9, 2015
Prior (Replaced) [Member]
Mar. 4, 2014
Prior (Replaced) [Member]
Stock repurchase program [Abstract]
 
 
 
 
 
 
Shares repurchased and retired, shares
50,699,000 
27,586,000 
 
5,061,000 
 
 
Payments for Repurchase of Common Stock, Before Commissions
$ 3,600,000,000 
$ 2,000,000,000 
 
$ 345,000,000 
 
 
Stock Repurchase Program, Remaining Authorized Repurchase Amount
14,500,000,000 
 
 
 
2,100,000,000 
 
Authorized amount
 
 
$ 15,000,000,000 
 
 
$ 7,800,000,000 
Stockholders' Equity Dividends (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 0 Months Ended
Mar. 29, 2015
Dec. 28, 2014
Mar. 30, 2014
Dec. 29, 2013
Mar. 29, 2015
Mar. 30, 2014
Mar. 9, 2015
Apr. 8, 2015
Subsequent Event
Dividends
 
 
 
 
 
 
 
 
Percentage increase common stock dividend per share announced
 
 
 
 
 
 
14.00% 
 
Dividends per share announced
$ 0.42 
$ 0.42 
$ 0.35 
$ 0.35 
$ 0.84 
$ 0.70 
 
$ 0.48 
Dividends
$ 702 
$ 710 
$ 599 
$ 599 
$ 1,412 
$ 1,198 
 
 
Amount of Increased Common Stock Dividends per Share Announced
 
 
 
 
 
 
$ 0.48 
 
Dividends Payable, Date Declared
 
 
 
 
 
 
 
Apr. 08, 2015 
Dividends Payable, Date to be Paid
 
 
 
 
 
 
 
Jun. 24, 2015 
Dividends Payable, Date of Record
 
 
 
 
 
 
 
Jun. 03, 2015 
Debt (Details) (USD $)
3 Months Ended
Mar. 29, 2015
Sep. 28, 2014
Short-term Debt [Line Items]
 
 
Line of Credit Facility, Initiation Date
Feb. 18, 2015 
 
Line of Credit Facility, Maximum Borrowing Capacity
$ 4,000,000,000 
 
Line of Credit Facility, Expiration Date
Feb. 18, 2020 
 
Line of Credit Facility, Interest Rate During Period
at the option of the Company, at either LIBOR (determined in accordance with the Revolving Credit Facility) plus a margin of 0.7% per annum or the Base Rate (determined in accordance with the Revolving Credit Facility), plus an initial margin of 0% per annum. 
 
Line of Credit Facility, Commitment Fee Percentage, per annum
0.05% 
 
Line of Credit Facility, Covenant Terms
maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in the Revolving Credit Facility, of not less than three to one at the end of each fiscal quarter 
 
Line of Credit Facility, Covenant Compliance
the Company was in compliance with the financial covenant 
 
Short-term debt
1,096,000,000 
Commercial Paper [Member]
 
 
Short-term Debt [Line Items]
 
 
Short-term debt, Maximum Borrowing Capacity
$ 4,000,000,000 
 
Short-term debt, Weighted Average Interest Rate
0.14% 
 
Minimum [Member] |
Commercial Paper [Member]
 
 
Short-term Debt [Line Items]
 
 
Short-term debt Instrument, Term
1 day 
 
Maximum [Member] |
Commercial Paper [Member]
 
 
Short-term Debt [Line Items]
 
 
Short-term debt Instrument, Term
397 days 
 
Weighted Average [Member] |
Commercial Paper [Member]
 
 
Short-term Debt [Line Items]
 
 
Short-term debt Instrument, Remaining Term
58 days 
 
Commitments and Contingencies (Details)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended 3 Months Ended
Mar. 29, 2015
Sep. 29, 2013
USD ($)
Mar. 29, 2015
China, Yuan Renminbi
CNY
Mar. 29, 2015
United States of America, Dollars
USD ($)
Resolution of governmental investigation [Line Items]
 
 
 
 
Resolution of governmental investigation, Amount
 
 
 6,088 
$ 975 
Legal Proceedings [Abstract]
 
 
 
 
ParkerVision verdict amount
 
$ 173 
 
 
Assessment of SEC and DOJ investigation
As previously disclosed, the Company discovered, and as a part of its cooperation with these investigations informed the SEC and the DOJ of, instances in which special hiring consideration, gifts or other benefits (collectively, benefits) were provided to several individuals associated with Chinese state-owned companies or agencies. Based on the facts currently known, the Company believes the aggregate monetary value of the benefits in question to be less than $250,000, excluding employment compensation. 
 
 
 
Commitments and Contingencies Purchase Obligations (Details) (USD $)
Mar. 29, 2015
Unrecorded Unconditional Purchase Obligation [Line Items]
 
Unrecorded obligations for remainder of fiscal 2015
$ 3,200,000,000 
Unrecorded obligations for fiscal 2016
1,200,000,000 
Unrecorded obligations for fiscal 2017
941,000,000 
Unrecorded obligations for fiscal 2018
797,000,000 
Unrecorded obligations for fiscal 2019
733,000,000 
Unrecorded obligations thereafter
208,000,000 
Inventories [Member]
 
Unrecorded Unconditional Purchase Obligation [Line Items]
 
Unrecorded obligations for remainder of fiscal 2015
2,500,000,000 
Unrecorded obligations for fiscal 2016
994,000,000 
Unrecorded obligations for fiscal 2017
794,000,000 
Unrecorded obligations for fiscal 2018
715,000,000 
Unrecorded obligations for fiscal 2019
665,000,000 
Unrecorded obligations thereafter
$ 185,000,000 
Commitments and Contingencies Capital and Operating Leases (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended
Mar. 29, 2015
Capital and operating leases [Abstract]
 
Description of Leasing Arrangements, Operating Leases
The Company leases certain of its land, facilities and equipment under noncancelable operating leases, with terms ranging from less than one year to 20 years and with provisions in certain leases for cost-of-living increases. 
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
 
Remainder of fiscal 2015 - Operating leases
$ 45 
Fiscal 2016 - Operating leases
80 
Fiscal 2017 - Operating leases
61 
Fiscal 2018 - Operating leases
33 
Fiscal 2019 - Operating leases
21 
Thereafter - Operating leases
$ 21 
Segment Information (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Sep. 28, 2014
Segment Reporting Information [Line Items]
 
 
 
 
 
Segment Reporting, Factors Used to Identify Entity's Reportable Segments
 
 
The Company is organized on the basis of products and services. The Company conducts business primarily through two reportable segments: QCT (Qualcomm CDMA Technologies) and QTL (Qualcomm Technology Licensing), and its QSI (Qualcomm Strategic Initiatives) reportable segment makes strategic investments 
 
 
Revenues
$ 6,894 
$ 6,367 
$ 13,993 
$ 12,989 
 
Earnings before taxes
1,539 
2,272 
3,837 
4,029 
 
Goodwill impairment charge
 
 
 
16 
 
Assets
47,173 
 
47,173 
 
48,574 
Long-lived assets impairment charges
 
 
 
444 
 
QCT [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenues
4,434 
4,243 
9,676 
8,859 
 
Earnings before taxes
750 
740 
1,896 
1,646 
 
Assets
3,412 
 
3,412 
 
3,639 
QTL [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenues
2,414 
2,071 
4,230 
3,971 
 
Earnings before taxes
2,162 
1,834 
3,741 
3,504 
 
Assets
475 
 
475 
 
161 
QSI [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenues
 
Earnings before taxes
(32)
(39)
(33)
(35)
 
Assets
614 
 
614 
 
484 
Reconciling Items [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenues
46 
53 
87 
159 
 
Earnings before taxes
(1,341)
(263)
(1,767)
(1,086)
 
Assets
42,672 
 
42,672 
 
44,290 
Nonreportable Segments [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenues
47 
53 
90 
162 
 
Earnings before taxes
(163)
(200)
(311)
(853)
 
Unallocated cost of equipment and services revenues [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Earnings before taxes
(74)
(75)
(152)
(148)
 
Unallocated acquisition-related expenses
63 
62 
129 
123 
 
Unallocated research and development expenses [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Earnings before taxes
(226)
(217)
(437)
(434)
 
Unallocated acquisition-related expenses
22 
23 
 
Unallocated selling, general and administrative expenses [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Earnings before taxes
(100)
(85)
(249)
(210)
 
Unallocated acquisition-related expenses
13 
25 
13 
 
Unallocated Other Income [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Earnings before taxes
(1,010)
(1,079)
(12)
 
Goodwill impairment charge
 
 
104 
 
 
Unallocated Investment Income, Net [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Earnings before taxes
232 
314 
462 
571 
 
Intersegment Eliminations [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenues
(1)
(3)
(3)
 
Earnings before taxes
(1)
 
United States of America, Dollars
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Resolution of governmental investigation, Amount
975 
 
 
 
 
United States of America, Dollars |
Unallocated Other Income [Member]
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Resolution of governmental investigation, Amount
 
 
$ 975 
 
 
Acquisitions (Details)
In Billions, except Per Share data, unless otherwise specified
Mar. 29, 2015
GBP (£)
Apr. 21, 2015
Subsequent Event
Apr. 21, 2015
United Kingdom, Pounds
Subsequent Event
GBP (£)
Apr. 21, 2015
United States of America, Dollars
Subsequent Event
USD ($)
Business Acquisition [Line Items]
 
 
 
 
Business Acquisition, Share Price
£ 9.00 
 
 
 
Business Acquisition, Total Price
 
 
£ 1.6 
$ 2.3 
Foreign Currency Exchange Rate, Remeasurement
 
1.4929 
 
 
Discontinued Operations (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended 12 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Sep. 28, 2014
Discontinued Operations and Disposal Groups [Abstract]
 
 
 
Proceeds from sale of discontinued operations, net of cash sold
$ 0 
$ 788 
$ 788 
Gain on sale of discontinued operations
665 
665 
Gain on sale of discontinued operations, net of income tax expense
 
 
$ 430 
Fair Value Measurements Fair Value Hierarchy (Details) (USD $)
In Millions, unless otherwise specified
Mar. 29, 2015
Assets, Fair Value Disclosure [Abstract]
 
Assets, Fair Value Disclosure, Recurring
$ 29,647 
Liabilities, Fair Value Disclosure [Abstract]
 
Total liabilities measured at fair value
300 
Level 1 [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Assets, Fair Value Disclosure, Recurring
4,346 
Liabilities, Fair Value Disclosure [Abstract]
 
Total liabilities measured at fair value
296 
Level 2 [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Assets, Fair Value Disclosure, Recurring
25,073 
Liabilities, Fair Value Disclosure [Abstract]
 
Total liabilities measured at fair value
Level 3 [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Assets, Fair Value Disclosure, Recurring
228 
Liabilities, Fair Value Disclosure [Abstract]
 
Total liabilities measured at fair value
Fair Value, Measurements, Recurring [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Cash equivalents
5,204 
Marketable Securities [Abstract]
 
U.S. Treasury securities and government-related securities
1,461 
Corporate bonds and notes
15,440 
Mortgage- and asset-backed securities
1,536 
Auction rate securities
47 
Common and preferred stock
1,391 
Equity funds
646 
Debt funds
3,597 
Total marketable securities
24,118 
Derivative instruments
Other investments
318 1
Liabilities, Fair Value Disclosure [Abstract]
 
Derivative instruments
Other liabilities
294 
Fair Value, Measurements, Recurring [Member] |
Level 1 [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Cash equivalents
2,453 
Marketable Securities [Abstract]
 
U.S. Treasury securities and government-related securities
252 
Corporate bonds and notes
Mortgage- and asset-backed securities
Auction rate securities
Common and preferred stock
676 
Equity funds
646 
Debt funds
Total marketable securities
1,574 
Derivative instruments
Other investments
318 1
Liabilities, Fair Value Disclosure [Abstract]
 
Derivative instruments
Other liabilities
294 
Fair Value, Measurements, Recurring [Member] |
Level 2 [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Cash equivalents
2,751 
Marketable Securities [Abstract]
 
U.S. Treasury securities and government-related securities
1,209 
Corporate bonds and notes
15,440 
Mortgage- and asset-backed securities
1,355 
Auction rate securities
Common and preferred stock
715 
Equity funds
Debt funds
3,597 
Total marketable securities
22,316 
Derivative instruments
Other investments
1
Liabilities, Fair Value Disclosure [Abstract]
 
Derivative instruments
Other liabilities
Fair Value, Measurements, Recurring [Member] |
Level 3 [Member]
 
Assets, Fair Value Disclosure [Abstract]
 
Cash equivalents
Marketable Securities [Abstract]
 
U.S. Treasury securities and government-related securities
Corporate bonds and notes
Mortgage- and asset-backed securities
181 
Auction rate securities
47 
Common and preferred stock
Equity funds
Debt funds
Total marketable securities
228 
Derivative instruments
Other investments
1
Liabilities, Fair Value Disclosure [Abstract]
 
Derivative instruments
Other liabilities
$ 0 
Fair Value Measurements Activity Between Levels of the Fair Value Hierarchy, Assets (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Auction Rate Securities [Member]
 
 
Activity for Marketable Securities Classified Within Level 3 of the Valuation Hierarchy [Roll Forward]
 
 
Beginning balance of Level 3
$ 83 
$ 83 
Total realized and unrealized gains or losses included in investment income, net
Total realized and unrealized gains or losses included in other comprehensive income
Purchases
Sales
Settlements
(36)
Transfers out of Level 3
Ending balance of Level 3
47 
83 
Mortgage- and asset-backed securities [Member]
 
 
Activity for Marketable Securities Classified Within Level 3 of the Valuation Hierarchy [Roll Forward]
 
 
Beginning balance of Level 3
186 
239 
Total realized and unrealized gains or losses included in investment income, net
Total realized and unrealized gains or losses included in other comprehensive income
(4)
Purchases
50 
49 
Sales
(41)
(18)
Settlements
(13)
(22)
Transfers out of Level 3
(2)
Ending balance of Level 3
$ 181 
$ 250 
Fair Value Measurements Nonrecurring Fair Value Measurements (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Impaired Long-Lived Assets Held and Used [Line Items]
 
 
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
$ 27 
 
Long-lived assets impairment charges
 
444 
Goodwill, Impaired [Abstract]
 
 
Goodwill impairment charge
 
16 
Unallocated Other Income [Member]
 
 
Goodwill, Impaired [Abstract]
 
 
Goodwill impairment charge
$ 104 
 
Marketable Securities (Details) (USD $)
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 30, 2014
Sep. 28, 2014
Mar. 29, 2015
U.S. Treasury securities and government-related securities [Member]
Sep. 28, 2014
U.S. Treasury securities and government-related securities [Member]
Mar. 29, 2015
Corporate bonds and notes
Sep. 28, 2014
Corporate bonds and notes
Mar. 29, 2015
Mortgage- and asset-backed securities [Member]
Sep. 28, 2014
Mortgage- and asset-backed securities [Member]
Mar. 29, 2015
Auction rate securities
Sep. 28, 2014
Auction rate securities
Mar. 29, 2015
Common and preferred stock
Sep. 28, 2014
Common and preferred stock
Mar. 29, 2015
Equity funds
Sep. 28, 2014
Equity funds
Mar. 29, 2015
Debt funds
Sep. 28, 2014
Debt funds
Apr. 21, 2015
Subsequent Event [Member]
Apr. 21, 2015
Subsequent Event [Member]
United Kingdom, Pounds
Apr. 21, 2015
Subsequent Event [Member]
United States of America, Dollars
Schedule of Marketable Securities [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted Marketable Securities
 
 
 
 
$ 140,000,000 
 
$ 2,900,000,000 
 
$ 717,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted Cash and Cash Equivalents, Current
24,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Threshold To Set Aside Marketable Securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,900,000,000 
2,800,000,000 
Foreign Currency Exchange Rate, Remeasurement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4929 
 
 
Total marketable securities - Current
10,063,000,000 
 
 
9,658,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total marketable securities - Noncurrent
14,055,000,000 
 
 
14,457,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading Securities [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading - Current
515,000,000 
 
 
511,000,000 
338,000,000 
320,000,000 
177,000,000 
191,000,000 
 
 
 
 
 
 
 
 
 
 
 
Trading - Noncurrent
608,000,000 
 
 
642,000,000 
23,000,000 
38,000,000 
345,000,000 
367,000,000 
240,000,000 
237,000,000 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale Securities [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale - Current
9,548,000,000 
 
 
9,147,000,000 
385,000,000 
805,000,000 
7,250,000,000 
6,274,000,000 
1,091,000,000 
1,063,000,000 
572,000,000 
192,000,000 
250,000,000 
813,000,000 
 
 
 
Available-for-sale - Noncurrent
12,659,000,000 
 
 
13,025,000,000 
715,000,000 
392,000,000 
7,668,000,000 
7,649,000,000 
205,000,000 
195,000,000 
47,000,000 
83,000,000 
819,000,000 
1,605,000,000 
646,000,000 
541,000,000 
2,559,000,000 
2,560,000,000 
 
 
 
Fair Value Option [Abstract]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value option - Current
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value option - Noncurrent
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
788,000,000 
790,000,000 
 
 
 
Effective ownership interest in debt fund (fair value option)
27.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Decrease) increase in fair value recognized in investment income
 
12,000,000 
18,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net gains recognized on debt securities classified as trading held at the end of the period
$ 14,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Marketable Securities Available-for-sale Securities (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 30, 2014
Mar. 29, 2015
Mar. 30, 2014
Sep. 28, 2014
Schedule of Available-for-sale Securities [Line Items]
 
 
 
 
 
Available-for-sale Equity Securities, Amortized Cost Basis
$ 1,654 
 
$ 1,654 
 
$ 1,769 
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax
383 
 
383 
 
575 
Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax
 
 
(6)
Available-for-sale Securities Equity Securities, Fair Value
2,037 
 
2,037 
 
2,338 
Available-for-sale Debt Securities (including debt funds), Amortized Cost Basis
19,940 
 
19,940 
 
19,582 
Available-for-sale Debt Securities (including debt funds), Accumulated Gross Unrealized Gain, before Tax
311 
 
311 
 
312 
Available-for-sale Debt Securities (including debt funds), Accumulated Gross Unrealized Loss, before Tax
(81)
 
(81)
 
(60)
Available-for-sale Debt Securities, Fair Value
20,170 
 
20,170 
 
19,834 
Contractual maturities of available-for-sale debt securities [Abstract]
 
 
 
 
 
Years to Maturity - Less Than One Year
2,818 
 
2,818 
 
 
Years to Maturity - One to Five Years
11,245 
 
11,245 
 
 
Years to Maturity - Five to Ten Years
1,363 
 
1,363 
 
 
Years to Maturity - Greater Than Ten Years
592 
 
592 
 
 
Years to Maturity - No Single Maturity Date
4,152 
 
4,152 
 
 
Realized Gains and Losses on Sales of Available-for-sale Securities [Abstract]
 
 
 
 
 
Gross Realized Gains
128 
227 
308 
343 
 
Gross Realized Losses
(30)
(5)
(37)
(8)
 
Net Realized Gains
98 
222 
271 
335 
 
Available-for-sale Securities [Abstract]
 
 
 
 
 
Cost
21,594 
 
21,594 
 
21,351 
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
694 
 
694 
 
887 
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
(81)
 
(81)
 
(66)
Fair Value
22,207 
 
22,207 
 
22,172 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
5,938 
 
5,938 
 
5,906 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
(69)
 
(69)
 
(38)
More than 12 months - Fair Value
324 
 
324 
 
675 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
(12)
 
(12)
 
(28)
U.S. Treasury securities and government-related securities [Member]
 
 
 
 
 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
395 
 
395 
 
279 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
(3)
 
(3)
 
(2)
More than 12 months - Fair Value
 
 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
 
 
Corporate bonds and notes
 
 
 
 
 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
4,211 
 
4,211 
 
4,924 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
(58)
 
(58)
 
(31)
More than 12 months - Fair Value
201 
 
201 
 
104 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
(10)
 
(10)
 
(4)
Mortgage- and asset-backed securities [Member]
 
 
 
 
 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
535 
 
535 
 
484 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
(1)
 
(1)
 
(1)
More than 12 months - Fair Value
26 
 
26 
 
52 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
 
 
(1)
Auction rate securities
 
 
 
 
 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
 
 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
 
 
More than 12 months - Fair Value
47 
 
47 
 
83 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
(1)
 
(1)
 
(1)
Common and preferred stock
 
 
 
 
 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
13 
 
13 
 
86 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
 
 
(3)
More than 12 months - Fair Value
12 
 
12 
 
52 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
 
 
(3)
Debt funds
 
 
 
 
 
Investments Classified as Available-for-sale in a Continuous Unrealized Loss Position Deemed to be Temporary [Abstract]
 
 
 
 
 
Less than 12 months - Fair Value
784 
 
784 
 
133 
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
(7)
 
(7)
 
(1)
More than 12 months - Fair Value
38 
 
38 
 
384 
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
$ (1)
 
$ (1)
 
$ (19)